1. Home
  2. GABC vs NKTR Comparison

GABC vs NKTR Comparison

Compare GABC & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo German American Bancorp Inc.

GABC

German American Bancorp Inc.

HOLD

Current Price

$51.06

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$73.16

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GABC
NKTR
Founded
1910
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.2B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
GABC
NKTR
Price
$51.06
$73.16
Analyst Decision
Buy
Strong Buy
Analyst Count
3
7
Target Price
$47.67
$146.67
AVG Volume (30 Days)
152.3K
676.7K
Earning Date
04-27-2026
05-07-2026
Dividend Yield
2.88%
N/A
EPS Growth
8.13
N/A
EPS
0.88
N/A
Revenue
$487,401,000.00
$307,711,000.00
Revenue This Year
$16.78
N/A
Revenue Next Year
$3.98
N/A
P/E Ratio
$58.00
N/A
Revenue Growth
37.80
86.00
52 Week Low
$37.19
$22.01
52 Week High
$52.23
$109.00

Technical Indicators

Market Signals
Indicator
GABC
NKTR
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
GABC
NKTR

About GABC German American Bancorp Inc.

German American Bancorp Inc is a bank holding company. The lines of business include the core banking segment and the wealth management segment. The core banking segment involves attracting deposits from the general public and using those funds to originate consumer, commercial, and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services, which involve providing trust, investment advisory, brokerage, and retirement planning services to customers. The company generates the majority of its revenue from the core banking segment.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Share on Social Networks: